Regenxbio RGNX Net unrealized gains (losses) on securities still held
Net unrealized gains (losses) on securities still held at other companies
Other financials
Where this comes from
Reported directly by Regenxbio in its filing.
Tagged under the XBRL concept us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax.
The official record: Regenxbio’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →
Ask your AI about Regenxbio's net unrealized gains (losses) on securities still held.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Regenxbio's net unrealized gains (losses) on securities still held?
- Regenxbio (RGNX) reported net unrealized gains (losses) on securities still held of -$183K in Q1 2026.
- How has Regenxbio's net unrealized gains (losses) on securities still held changed year-over-year?
- Regenxbio's net unrealized gains (losses) on securities still held decreased by 771.4% year-over-year, from -$21K to -$183K.
- What is the long-term trend for Regenxbio's net unrealized gains (losses) on securities still held?
- Over 2 years (2021 to 2024), Regenxbio's net unrealized gains (losses) on securities still held has grown at a 32.0% compound annual growth rate (CAGR), from -$2.21M to $3.85M.
- What does net unrealized gains (losses) on securities still held mean?
- This reflects the change in the fair value of investment securities held by the company that have not yet been sold. These gains or losses are recognized in equity rather than the income statement, representing potential future liquidity or risk exposure. It provides insight into the performance of the company's treasury or investment portfolio outside of core operations.